ANALYTICAL & LABORATORY EQUIPMENT
The new test bed represents an
exciting opportunity for smaller firms to develop their solutions
therapies. With the launch of the Test Bed, along with an Innovation Accelerator to support regenerative medicine start-ups and established growth companies, and a Workforce Development programme, WFIRM and ReMDO have established a regenerative medicine business landscape called the Regenerative Medicine Hub (RegenMed Hub). Te RegenMed Hub is one of the fastest growing intersections of biotechnology innovation and business in the nation, making Winston-Salem and the region at large the go-to destination for innovation in regenerative medicine technology. “Te RegeneratOR Test Bed is a game-changer for companies to test and develop their products, because regenerative medicine all starts with the cell,” says Gary Green, chief operating officer for ReMDO. Currently, the Test Bed is the only
available lab space where an entire cell production process can be put inside an enclosed system in which companies can test and measure the tangible benefit of cytocentric cell manufacturing to their specific production process. “If you can create a more conducive
environment to cell isolation, expansion, and growth, you can create more efficacious cells, both in terms of the number of cells produced and the efficacy of the cells. Te value all goes back to the cell and the ability to create a positive environment that makes for more regeneration and better cells,” says Green. Te Test Bed is a free service. “Startups, emerging companies and established companies with emerging products in the regenerative medicine space are able to take advantage of the facility at no cost to them, so that they can build their prototypes, in terms of manufacturing, and reduce product development costs dramatically,” says Atala.
The RegeneratOR Test Bed is a potential game-changer for US companies
STATE-OF-THE-ART TECHNOLOGIES Companies such as New York-based BioSpherix provide technologies and resources for firms in the RegenMed Hub. Te company has focused on the design and manufacture of cytocentric cell incubation, processing, and production systems, a unique equipment platform that controls critical cell process parameters at physiologic levels more thoroughly than conventional approaches. BioSpherix Medical is the exclusive supplier of the only cytocentric isolator called the Xvivo system model X2, used by cell and gene therapy developers globally to economically produce the most potent cells. With the Xvivo system, any process, any equipment, any automation – all the top technology from other manufacturers – can be incorporated into the system. Te modularity of the Xvivo system
allows it to be flexible enough to meet the requirements of various therapies and scalability allows it to be redesigned, reconfigured, and expanded as the needs of the end user shift or change.
Cytocentric cell manufacturing keeps the critical cell process parameters at optimum physiologic levels
www.scientistlive.com 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
